Inveox, which has developed a system to digitise, automate and connect pathology laboratories, has raised €17m (US$19m) Series A funding from unnamed investors. Founded in 2017, the Munich based company intends to begin the series-level production of its AI-supported automation system in order to make cancer diagnoses faster and more reliable. “We want to help…
©2023 All rights reserved LaingBuisson 
 Series A funding from unnamed investors.){kind=link}